| 相似文献(共20条): |
| [1]、 | The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation : A PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Substudy[J].Journal of the American College of Cardiology |
| [2]、 | Gaurav Mohan,Naved Aslam,Gurpreet Singh Wander.Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial[J].Indian heart journal,2013,65(3):348-349. |
| [3]、 | Quality of Life Assessment in the Randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Trial of Patients at Risk for Stroke With Nonvalvular Atrial Fibrillation[J].Journal of the American College of Cardiology |
| [4]、 | Percutaneous Left Atrial Appendage Occlusion with a Watchman Device Following Recurrent Stroke on Warfarin and Rivaroxaban in Patient with Paroxysmal Atrial Fibrillation[J].Heart, lung & circulation |
| [5]、 | Erin A. Fender,Jawad G. Kiani,David R. HolmesJr.Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation[J].Current atherosclerosis reports,2016,18(11):65. |
| [6]、 | Sophie Weiwei Gao,Emilie Prudence Belley-Côté,Kevin John Um,Richard Paul Whitlock.Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation[J].The American journal of cardiology,2019,123(8):1385. |
| [7]、 | Mingjie Fu,Zheng Qin,Shuai Zheng,Yueping Li,Shiwei Yang,Yingxin Zhao,Chengping Hu,Kuo Zhou,Yujie Zhou,Xu Meng.Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation[J].The American journal of cardiology,2019,123(1):50-56. |
| [8]、 | Miguel Valderrábano,Matthew J. Price.Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation[J].Methodist DeBakey Cardiovascular Journal,2015,11(2):94-99. |
| [9]、 | Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years[J].JACC: Cardiovascular Interventions |
| [10]、 | Reddy VY,Holmes D,Doshi SK,Neuzil P,Kar S.Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry[J].Circulation,2011,123(4):417-424. |
| [11]、 | Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy[J].Journal of the American College of Cardiology |
| [12]、 | Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy : The PREVAIL Trial[J].Journal of the American College of Cardiology |
| [13]、 | The clinical impact of incomplete left atrial appendage closure with the watchman device in patients with atrial fibrillation A PROTECT AF (percutaneous closure of the left Atrial appendage versus warfarin therapy for prevention of stroke in patients with[J].岭南心血管病杂志(英文版) |
| [14]、 | Block PC.Percutaneous left atrial appendage closure in a patient with atrial fibrillation[J].Nature clinical practice. Cardiovascular medicine,2006,3(8):456-9; quiz 460. |
| [15]、 | Fountain RB,Holmes DR,Chandrasekaran K,Packer D,Asirvatham S,Van Tassel R,Turi Z.The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial[J].American heart journal,2006,151(5):956-961. |
| [16]、 | Peter C. Block,Steven Burstein,Paul N. Casale,Paul H. Kramer,Paul Teirstein,David O. Williams,Mark Reisman.Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-Year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study[J].JACC: Cardiovascular Interventions,2009,2(7):594-600. |
| [17]、 | Self-Expandable Device for Percutaneous Closing of Left Atrial Appendage With Organized Thrombus in a Patient With Permanent Atrial Fibrillation[J].The Canadian journal of cardiology |
| [18]、 | Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation: Testing the Noninferiority Margins[J].JACC: Cardiovascular Interventions |
| [19]、 | Lluis Asmarats,Jean-Bernard Masson,Paolo A. Pagnotta,Stéphane Cook,Mike Foresti,Réda Ibrahim,Adam Sukiennik,Robert Sabiniewicz,Diego Maffeo,Julio Carballo,Ignacio Cruz-González,Carmelo Grasso,Francesco Pisano,Gaetano Senatore,Giuseppe Tarantini,Adolphe Kasongo,Mauro Chiarito,Serban Puricel,Josep Rodés-Cabau.Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience[J].JACC: Cardiovascular Interventions,2018,11(19):1932-1941. |
| [20]、 | Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation: Testing the Noninferiority Margins[J].JACC: Cardiovascular Interventions |
